Symbols

How did CytomX Therapeutics' revenue and expenses trend in Q4 2024?

5/7/2025 10:32am

Aime

CytomX Therapeutics' revenue and expenses in Q4 2024 showed a revenue of $38.09 million and total expenses of $18.88 million, with $14.79 million being R&D expenses¹.

CTMX R&D Expenses, Total Revenue...

Source:

1. CTMX Revenue (Q4 2024), R&D Expenses (Q4 2024), SG&A Expenses (Q4 2024), Net Income (Q4 2024)